Type of HCAI | Prevalence ranges (%) (Median) | I2 (%) | Tau-square | P-value |
---|---|---|---|---|
Before sensitivity testing | ||||
 PN | 2.4–85.7 (20.6) | 98 | 0.0538 | < 0.01 |
 BSI | 2.4–62.6 (19.8) | 98 | 0.0192 | < 0.01 |
 UTI | 0.5–65.6 (16.9) | 97 | 0.0189 | < 0.01 |
 SSI | 1.8–70.5 (13.6) | 98 | 0.0204 | 0 |
 Unknowna | 1.6–63.4 (14.9) | 99 | 0.0167 | 0 |
After 1st sensitivity testingb | ||||
 PN | 2.4–85.7 (20.6) | 97 | 0.0594 | < 0.01 |
 BSI | 2.4–48.9 (19.5) | 89 | 0.0123 | < 0.01 |
 UTI | 0.5–51.4 (16.9) | 97 | 0.0151 | < 0.01 |
 SSI | 1.8–70.5 (11.7) | 98 | 0.0213 | 0 |
 Unknowna | 3.9–63.4 (14.0) | 98 | 0.0178 | < 0.01 |
After 2nd sensitivity testinga | ||||
 PN | 2.4–85.7 (20.6) | 98 | 0.0831 | < 0.01 |
 BSI | 2.4–41.2 (20.0) | 93 | 0.0124 | < 0.01 |
 UTI | 0.5–28.6 (19.8) | 97 | 0.0094 | < 0.01 |
 SSI | 2.3–69.7 (12.4) | 97 | 0.0153 | < 0.01 |
 Unknowna | 3.9–39.1 (13.5) | 98 | 0.0154 | < 0.01 |